Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai, developed and manufactured by Henlius independently,...
United States Jason Zhu Wenjie Zhang Hanquyou Zercepac Prnewswire Shanghai Henlius Biotech Inc Technical Guidelines For The Development
Source: prnewswire.com